Medroxyprogesterone acetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for medroxyprogesterone acetate and what is the scope of patent protection?
Medroxyprogesterone acetate
is the generic ingredient in seven branded drugs marketed by Pfizer, Amneal, Amphastar Pharms Inc, Cipla, Eugia Pharma, Hikma, Hong Kong, Sandoz, Sun Pharm, Teva Pharms Usa, Xiromed, Amarin Pharms, Solvay, Esi , Barr, Duramed Pharms Barr, and Upsher Smith Labs, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.There are nineteen drug master file entries for medroxyprogesterone acetate. Twenty-four suppliers are listed for this compound.
Summary for medroxyprogesterone acetate
| US Patents: | 0 |
| Tradenames: | 7 |
| Applicants: | 17 |
| NDAs: | 25 |
| Drug Master File Entries: | 19 |
| Finished Product Suppliers / Packagers: | 24 |
| Raw Ingredient (Bulk) Api Vendors: | 78 |
| Clinical Trials: | 123 |
| Patent Applications: | 7,017 |
| Drug Prices: | Drug price trends for medroxyprogesterone acetate |
| What excipients (inactive ingredients) are in medroxyprogesterone acetate? | medroxyprogesterone acetate excipients list |
| DailyMed Link: | medroxyprogesterone acetate at DailyMed |
Recent Clinical Trials for medroxyprogesterone acetate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Rajavithi Hospital | N/A |
| Bezmialem Vakif University | N/A |
| Oregon Health and Science University | Early Phase 1 |
Pharmacology for medroxyprogesterone acetate
| Drug Class | Progestin |
Medical Subject Heading (MeSH) Categories for medroxyprogesterone acetate
Anatomical Therapeutic Chemical (ATC) Classes for medroxyprogesterone acetate
US Patents and Regulatory Information for medroxyprogesterone acetate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | MEDROXYPROGESTERONE ACETATE | medroxyprogesterone acetate | INJECTABLE;INJECTION | 214309-001 | Jan 5, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eugia Pharma | MEDROXYPROGESTERONE ACETATE | medroxyprogesterone acetate | INJECTABLE;INJECTION | 212844-001 | Aug 31, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Amphastar Pharms Inc | MEDROXYPROGESTERONE ACETATE | medroxyprogesterone acetate | INJECTABLE;INJECTION | 077334-001 | Nov 28, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Eugia Pharma | MEDROXYPROGESTERONE ACETATE | medroxyprogesterone acetate | INJECTABLE;INJECTION | 212824-001 | Aug 22, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pfizer | DEPO-PROVERA | medroxyprogesterone acetate | INJECTABLE;INJECTION | 020246-001 | Oct 29, 1992 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Solvay | CURRETAB | medroxyprogesterone acetate | TABLET;ORAL | 085686-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Esi | CYCRIN | medroxyprogesterone acetate | TABLET;ORAL | 089386-001 | Sep 9, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for medroxyprogesterone acetate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | DEPO-PROVERA | medroxyprogesterone acetate | INJECTABLE;INJECTION | 012541-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | DEPO-SUBQ PROVERA 104 | medroxyprogesterone acetate | INJECTABLE;SUBCUTANEOUS | 021583-001 | Dec 17, 2004 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | DEPO-PROVERA | medroxyprogesterone acetate | INJECTABLE;INJECTION | 012541-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
